SubsidieMeestersSWAN: Blitzscaling the early detection of skin cancer
Swan offers rapid, full-body dermoscopic skin cancer detection using advanced AI and imaging technologies, enhancing early diagnosis and treatment accessibility for all stakeholders.
Projectdetails
Introduction
Swan is a breakthrough solution to the enduring problem of detecting skin cancer early. For the first time, Swan enables full-body scanning at dermoscopic resolution and in less than 3 minutes to the benefit of all stakeholders: patients, physicians, hospitals, and payers.
Key Features
The solution captures key data that dermatologists acutely need for early diagnosis and brings breakthrough AI triage assistance to flag concerning lesions.
Benefits
- Significant medical time is saved in the process.
- For patients, the impact is:
- Faster access to treatment when needed.
- Fewer unnecessary biopsies.
- Peace of mind.
Technology
The solution combines hardware and software and is at the crossroads of cutting-edge, patented technologies in:
- Real-time 3D human avatar generation.
- Advanced robotic control.
- Image processing.
- AI classification of lesions.
Ambition
Our ambition is to make best-in-class skin cancer screening accessible to everyone, everywhere, and finally help dermatology make a quantum leap forward.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.500.000 |
| Totale projectbegroting | € 3.920.366 |
Tijdlijn
| Startdatum | 1-7-2022 |
| Einddatum | 31-12-2024 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- SQUAREMINDpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
MUlti-spectral Scattering matrix for Enhanced skin imagingThe ERC REMINISCENCE project developed the DeepInsight microscope, enabling advanced non-invasive 3D imaging for early melanoma detection and skin disease analysis, with plans for commercialization. | ERC POC | € 150.000 | 2024 | Details |
Accurate quantification of neurologic disease over timeThe project aims to develop CHRONOS, an AI-driven diagnostic tool using synthetic biomaps to enable earlier and more accurate detection of brain tumors, facilitating timely clinical decisions. | ERC POC | € 150.000 | 2025 | Details |
Advancing stroke care with cutting-edge ultrasound biomarkers for Neurocritical CareResolve Stroke aims to enhance ultrasound imaging with the SYLVER system to improve stroke diagnosis and management through innovative biomarkers, making timely detection more accessible and effective. | EIC Transition | € 2.493.436 | 2025 | Details |
Digital Skintyping Platform based on dermoscopy & AII-Parse ontwikkelt een digitaal platform dat AI gebruikt om huidtype te analyseren via dermatoscoopbeelden, met als doel het risico op huidkanker te verminderen en monitoring te verbeteren. | MIT Haalbaarheid | € 18.888 | 2022 | Details |
MUlti-spectral Scattering matrix for Enhanced skin imaging
The ERC REMINISCENCE project developed the DeepInsight microscope, enabling advanced non-invasive 3D imaging for early melanoma detection and skin disease analysis, with plans for commercialization.
Accurate quantification of neurologic disease over time
The project aims to develop CHRONOS, an AI-driven diagnostic tool using synthetic biomaps to enable earlier and more accurate detection of brain tumors, facilitating timely clinical decisions.
Advancing stroke care with cutting-edge ultrasound biomarkers for Neurocritical Care
Resolve Stroke aims to enhance ultrasound imaging with the SYLVER system to improve stroke diagnosis and management through innovative biomarkers, making timely detection more accessible and effective.
Digital Skintyping Platform based on dermoscopy & AI
I-Parse ontwikkelt een digitaal platform dat AI gebruikt om huidtype te analyseren via dermatoscoopbeelden, met als doel het risico op huidkanker te verminderen en monitoring te verbeteren.